PJ34, a PARP1 inhibitor, attenuates acute allograft rejection after murine heart transplantation via regulating the CD4 + T lymphocyte response

2020 ◽  
Author(s):  
Xing Chen ◽  
Yajun Huang ◽  
Dashuai Wang ◽  
Nianguo Dong ◽  
Xinling Du
1998 ◽  
Vol 32 (2) ◽  
pp. 405-412 ◽  
Author(s):  
Thomas J Dengler ◽  
Rainer Zimmermann ◽  
Klaus Braun ◽  
Margit Müller-Bardorff ◽  
Jörg Zehelein ◽  
...  

2018 ◽  
Vol 143 (25) ◽  
pp. 1864-1865
Author(s):  
Walter Land

AbstractThe first clinical use of the “Munich antilymphocyte globulin” (ALG) at the occasion of the first successful human heart transplantation is briefly described. The cardiac transplantation was carried out by Christiaan Barnard and his team in Cape Town, South Africa, in 1968. The patient developed an acute allograft rejection which could be successfully reversed within three weeks using the intravenous administration of ALG. This event can be regarded as the beginning of a success story of ALG in its use as a powerful immunosuppressive agent in all categories of clinical organ transplantation.


1998 ◽  
Vol 31 ◽  
pp. 34-35
Author(s):  
G.M. Mullen ◽  
M.A. Silver ◽  
C.E. Lawless ◽  
J. Mendez ◽  
P.C. Barath ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document